about
Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?The role of different social contexts in shaping influenza transmission during the 2009 pandemicCan reactive school closures help critical care provision during the current influenza pandemic?Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data.Using time-use data to parameterize models for the spread of close-contact infectious diseases.Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patterns.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling.Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.Transition to Parenthood and HIV Infection in Rural Zimbabwe.Social Contact Structures and Time Use Patterns in the Manicaland Province of ZimbabweMeasles immunity gaps and the progress towards elimination: a multi-country modelling analysis.Clustering of contacts relevant to the spread of infectious disease.The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe.Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.The relative importance of frequency of contacts and duration of exposure for the spread of directly transmitted infections.Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy.Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system.Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.Cost-benefit analysis of controlling the spotted wing drosophila (Drosophila suzukii (Matsumura)) spread and infestation of soft fruits in Trentino, Northern Italy.Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic.Measurement and interpretation of pneumococcal IgG levels for clinical management.The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: a cost utility epidemiological assessment of vector control measures.The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis BThe current burden of pneumococcal disease in England and WalesA longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK settingAntibody Responses to Nasopharyngeal Carriage ofStreptococcus pneumoniaein Adults: A Longitudinal Household StudyThe impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness studyAssessing the burden of influenza and other respiratory infections in England and WalesEstimating the transmission parameters of pneumococcal carriage in householdsThe 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and WalesThe potential cost-effectiveness of acellular pertussis booster vaccination in England and WalesAusterity, measles and mandatory vaccination: cross-regional analysis of vaccination in Italy 2000–14A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact InfectionsMeasles vaccination: no time to restStudy design and protocol for investigating social network patterns in rural and urban schools and households in a coastal setting in Kenya using wearable proximity sensors
P50
Q28391723-CE452493-3FFD-40DD-87C6-CF17B04254FBQ28743870-2F627987-61DE-4F65-8BBF-F31B092FA582Q30368968-955516DB-7E7A-4277-A4F0-096684D3C14FQ30383805-D6F70BF0-0576-40BA-A114-DD7D7ABB885FQ33285339-E6F56E44-2BE2-477A-8CAB-66D4198B7AFCQ33370506-A363559C-2204-47C2-9170-AEDE3C31D6E6Q33551026-EA3B52E6-B8EF-4BAB-BD47-E4CC017F1A4AQ34077160-75F6C652-7607-45A1-BCD9-A4DEB23C237CQ34683751-77BB9687-E19C-428D-BDEE-5BCA873EA80FQ35138184-18A340B4-2050-4E6E-B295-79FC5FDE0B4BQ35213237-5479C6A2-F51A-4BE3-BA5B-139DD3C6DBF5Q35793500-C3988C24-44B7-4B8E-9F73-EC379D803078Q36148220-71CF13F5-1A3C-4E57-B3CB-CDE8923C71A7Q36252723-CB3321AE-EF16-4054-A227-D6EF07E87E89Q38625202-9A17EE40-DD90-47D9-8A65-5807A3577571Q39379100-F89A3266-71AC-4CD4-A38F-F3500FB779E3Q39429303-39D28FAF-B406-4A26-B877-476C6269BBDEQ40476803-09790A20-CFD1-42E6-B1D9-12F9189DC010Q42226647-CE39ED68-874C-4A72-87D0-1BB56111F419Q42279283-AE14D54E-E4C9-4D25-9F21-CF7E5D56148FQ43533804-B030711E-8D4C-45A4-B4BD-21FB44231C13Q43836508-18254CFA-64F1-415A-80B2-4CF72602B804Q43912397-EA46C77E-71A4-4523-88AC-26C6F93AC56DQ47864080-905EC982-DB42-4DA1-BE72-30AACDD370FFQ51059800-C3828B28-8EF5-442D-8897-31A555B9F98DQ52010599-E41297F6-745B-4C90-A023-531CEE06C7B5Q55359786-A13C6778-BE34-47C2-8187-9B2E2737FC88Q56968706-7CB035CD-7DDD-4B54-88B0-2BAD027430CBQ57385772-C0E22A42-5E11-4381-85D2-ABBB3E391CDAQ57385775-4CA5F524-B966-49FF-9761-1E103D8156D4Q57385776-2EFA36A9-4C59-4BB0-86C7-A6E9079037C3Q57395637-6C295210-977B-41BC-807C-9AE0086C60D8Q57613559-4D3B0885-F2F0-4947-9DFA-FDC7F2A87BD4Q57613565-AA949DB2-2E2E-491D-A2FF-A8F15CBD4754Q57613569-77B9F151-9B5C-4E31-ACB1-9F60A72B7DA8Q57613574-5A761604-E9C0-4814-89D6-AB52B6BE5F90Q57760101-47C03D8F-6607-4F59-9A58-883FFEF15F49Q91633180-F4C3AF2C-6E47-40D9-80A9-3890E4392180Q91738498-745FC210-AB1F-487C-851A-5EE1D495C988Q93137537-5930A8AD-E461-4EDA-9661-E65509B0EFFF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alessia Melegaro
@ast
Alessia Melegaro
@en
Alessia Melegaro
@es
Alessia Melegaro
@nl
Alessia Melegaro
@sl
type
label
Alessia Melegaro
@ast
Alessia Melegaro
@en
Alessia Melegaro
@es
Alessia Melegaro
@nl
Alessia Melegaro
@sl
prefLabel
Alessia Melegaro
@ast
Alessia Melegaro
@en
Alessia Melegaro
@es
Alessia Melegaro
@nl
Alessia Melegaro
@sl
P106
P31
P496
0000-0003-2221-8898